SEC Filing Summary for Astrana Health, Inc.

This filing details a transaction by Dai, Weili, a director at Astrana Health, Inc. On June 10, 2026, 4,525 restricted shares of common stock were granted. These shares, acquired under the Issuer's 2024 Equity Incentive Plan, will vest on the earlier of June 10, 2027, or the date of the Issuer's 2027 annual meeting of stockholders. Following this transaction, the post-transaction shares owned by Dai, Weili amount to 18,188. The transaction code is "A", indicating acquisition, with a price per share of 0.0, suggesting these were granted shares rather than purchased. The filing is Form 4, indicating a change in beneficial ownership.